Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Xiaoman He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6662-9440; OpenAlex author ID A5034807803. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. O-GlcNAcylation of FBP1 promotes pancreatic cancer progression by facilitating its Lys48-linked polyubiquitination in hypoxic environments. First author DOI 10.1038/s41389-025-00555-4↗
  2. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. Co-author DOI 10.1038/s41418-022-00984-3↗
  3. A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth. Co-author DOI 10.2147/ott.s246969↗
  4. Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer. Co-author DOI 10.7150/jca.27590↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Zhu · 2 shared papers, 2022–2025 · strength 0.49
  2. Yulian Wu · 3 shared papers, 2019–2022 · strength 0.37
  3. Wei Feng · 1 shared paper, 2025 · strength 0.33
  4. Lei Zheng · 2 shared papers, 2020–2022 · strength 0.28
  5. Jiali Gong · 1 shared paper, 2022 · strength 0.16
  6. Bo Zhang · 1 shared paper, 2020 · strength 0.12
  7. Yue‐Feng Zhang · 1 shared paper, 2019 · strength 0.09
  8. Muxing Kang · 1 shared paper, 2019 · strength 0.09
  9. Yizhao Zhou · 1 shared paper, 2019 · strength 0.09
  10. Pengping Li · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.